Stifel Financial’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,641
| Closed | -$797K | – | 3381 |
|
|
2024
Q3 | $797K | Sell |
27,641
-2,682
| -9% | -$77.3K | ﹤0.01% | 2378 |
|
|
2024
Q2 | $1.16M | Buy |
30,323
+8,600
| +40% | +$330K | ﹤0.01% | 2070 |
|
|
2024
Q1 | $1.28M | Buy |
21,723
+1,807
| +9% | +$106K | ﹤0.01% | 2039 |
|
|
2023
Q4 | $1.19M | Sell |
19,916
-10,118
| -34% | -$606K | ﹤0.01% | 2022 |
|
|
2023
Q3 | $1.14M | Buy |
30,034
+12,016
| +67% | +$457K | ﹤0.01% | 1965 |
|
|
2023
Q2 | $1.64M | Buy |
18,018
+1,300
| +8% | +$118K | ﹤0.01% | 1766 |
|
|
2023
Q1 | $1.1M | Buy |
16,718
+9,508
| +132% | +$627K | ﹤0.01% | 1982 |
|
|
2022
Q4 | $373K | Buy |
7,210
+558
| +8% | +$28.9K | ﹤0.01% | 2637 |
|
|
2022
Q3 | $454K | Buy |
+6,652
| New | +$454K | ﹤0.01% | 2480 |
|